UNIVERSITY OF MIAMI

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1925-01-01

Employees: 10K

Market Cap: -

Website: https://continue.miami.edu/packagedetail.aspx

Clinical Trials

Effects of Human Leptin Replacement

Phase 2

Completed

Conditions: Diabetes
Metabolic Syndrome
Obesity

Interventions: Drug: Recombinant methionyl human leptin

First Posted Date: 2008-04-14

Last Posted Date: 2020-02-13

Lead Sponsor: University of Miami

Target Recruit Count: 3

Registration Number: NCT00657605

Locations: 🇺🇸
University of Miami Miller School of Medicine, Center on Pharmacogenomics, Miami, Florida, United States

Topical Imiquimod in Conjunction With Nd:YAG Laser for Tattoo Removal

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Imiquimod, 5% cream

First Posted Date: 2008-03-19

Last Posted Date: 2018-03-22

Lead Sponsor: University of Miami

Target Recruit Count: 3

Registration Number: NCT00638651

Locations: 🇺🇸
Mohs, Dermatologic and Laser Surgery, Miami, Florida, United States

A Waitlist-Controlled Trial of the Unified Protocol for the Treatment of Emotional Disorders in Adolescents

Not Applicable

Completed

Conditions: Depression
Anxiety Disorders

Interventions: Behavioral: Unified Protocol for Adolescents (UP-A)

First Posted Date: 2008-03-05

Last Posted Date: 2014-12-19

Lead Sponsor: University of Miami

Target Recruit Count: 51

Registration Number: NCT00628888

Locations: 🇺🇸
Child and Adolescent Mood and Anxiety Treatment (CAMAT) Program, Miami, Florida, United States

Characteristics and Disease Progression of Mixed Connective Tissue Disease and Systemic Lupus Erythematosus

Recruiting

Conditions: Mixed Connective Tissue Disease (MCTD)
Systemic Lupus Erythematosus (SLE)

First Posted Date: 2007-12-28

Last Posted Date: 2025-03-10

Lead Sponsor: University of Miami

Target Recruit Count: 400

Registration Number: NCT00582881

Locations: 🇺🇸
University of Miami Miller School of Medicine, Miami, Florida, United States

Vaccine Therapy in Patients With Stages IIIB/IV Non-Small Cell Lung Cancer Who Have Finished First-Line Chemotherapy

Phase 1

Terminated

Conditions: Lung Cancer

Interventions: Biological: Allogeneic B7.1/HLA-A1
Other: Placebo

First Posted Date: 2007-09-24

Last Posted Date: 2017-10-16

Lead Sponsor: University of Miami

Target Recruit Count: 1

Registration Number: NCT00534209

Locations: 🇺🇸
Memorial Regional Hospital, Hollywood, Florida, United States
🇺🇸
University of Miami Sylvester Comprehensive Cancer Center, Miami, Florida, United States

Myfortic vs. Cellcept in Kidney Transplant Recipients

Phase 2

Completed

Conditions: End Stage Renal Disease

Interventions: Drug: Mycophenolate Sodium Delayed Release Tablets
Drug: Mycophenolate Mofetil

First Posted Date: 2007-09-21

Last Posted Date: 2023-09-28

Lead Sponsor: University of Miami

Target Recruit Count: 150

Registration Number: NCT00533624

Locations: 🇺🇸
University of Miami Miller School of Medicine, Miami, Florida, United States

Rapamycin Versus Mycophenolate Mofetil in Kidney-Pancreas Recipients

Phase 2

Completed

Conditions: Type 1 Diabetes

Interventions: Drug: Mycophenolate Mofetil
Drug: Rapamycin
Drug: Tacrolimus
Drug: Steroids

First Posted Date: 2007-09-21

Last Posted Date: 2017-07-12

Lead Sponsor: University of Miami

Target Recruit Count: 170

Registration Number: NCT00533442

Locations: 🇺🇸
University of Miami, Miller School of Medicine, Miami, Florida, United States

The Magnetic Resonance Imaging Evaluation of Doxorubicin Cardiotoxicity

Phase 1

Completed

Conditions: Breast Cancer

First Posted Date: 2007-09-17

Last Posted Date: 2008-06-04

Lead Sponsor: University of Miami

Target Recruit Count: 3

Registration Number: NCT00530101

Locations: 🇺🇸
University of Miami Dept of Radiology, Miami, Florida, United States
🇺🇸
University of Miami Dept of Hematology/Oncology, Miami, Florida, United States

Optimal Fluid Resuscitation for Trauma Patients

Completed

Conditions: Trauma

First Posted Date: 2007-09-10

Last Posted Date: 2013-02-22

Lead Sponsor: University of Miami

Target Recruit Count: 119

Registration Number: NCT00527098

Locations: 🇺🇸
Ryder Trauma Center, Miami, Florida, United States

Efficacy of Polypodium Leucotomos Extract Decreasing UVA Premutagenic and Photoaging Markers

Phase 2

Completed

Conditions: Skin Abnormalities
Aging

Interventions: Drug: Polypodium leucotomos

First Posted Date: 2007-08-27

Last Posted Date: 2019-06-18

Lead Sponsor: University of Miami

Target Recruit Count: 10

Registration Number: NCT00520910

Locations: 🇺🇸
University of Miami Skin Research Group Office, Miami, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy